Type 1 diabetes management during hospitalization remains

The gap

Evidence profile

Sourced from the limitations and synthesized of the source papers, classified as general, drawn from work published between 2019 and 2026, spanning 3 journals. Those papers have been cited 14 times in total.

Supporting evidence — 3 representative gaps

• Continuous glucose monitoring in diabetes management – evidence, applications, and future perspectives: A comprehensive review of recent developments (2026) · Annales Academiae Medicae Silesiensis · doi

  trials, differences lower adherence and Major limitations identified in studies of CGM in type 1 diabetes include substantial heterogeneity among in study design and population characteristics, and potential bias from industry sponsorship. The exclusion of participants with the predominant use of HbA1c as a primary endpoint may reduce generalizability and fail to capture the full range of glycemic variability. Furthermore, the growing integration of CGM into automated insulin delivery systems reduces the re-levance of findings derived from studies assessing stand-alone monitoring [13].

  generallimitationsevidence 5/5
  Keywords: trials differences lower adherence major limitations identified type diabetes include substantial heterogeneity among design population
• Diabetes in the Hospital (2021) · Deutsches Ärzteblatt international · cited 14× · doi

  Type 1 diabetes management during hospitalization remains understudied relative to type 2; while one study reports type 1 comprises only 0.5% of hospitalized cases and shows longer stays for certain age groups, none of these papers systematically examine inpatient management protocols, glycemic targets, or insulin delivery strategies specific to type 1 diabetes in hospital settings.

  generalsynthesizedevidence 5/5
  Keywords: type diabetes management during hospitalization remains understudied relative
• In-hospital screening for diabetes mellitus with HbA1c in an internal medicine department was not useful; a prospective pilot study (2019) · Romanian Journal of Internal Medicine · doi

  Screening protocols for undiagnosed diabetes in hospitalized patients are addressed in only one study, which found HbA1c screening in an internal medicine department was not useful due to high exclusion rates and low yield; no other papers evaluate alternative screening methods, optimal timing, or cost-effectiveness of inpatient diabetes case-finding across different hospital settings or patient populations.

  generalsynthesizedevidence 5/5
  Keywords: screening protocols undiagnosed diabetes hospitalized patients addressed only

Questions about this gap